» Articles » PMID: 34497450

Prediction of the Severity of Colorectal Lesion by Fecal Hemoglobin Concentration Observed During Previous Test in the French Screening Program

Overview
Specialty Gastroenterology
Date 2021 Sep 9
PMID 34497450
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The rate of positive tests using fecal immunochemical test (FIT) does not decrease with subsequent campaigns, but the positive predictive value of advanced neoplasia significantly decreases in subsequent campaign after a first negative test. A relationship between the fecal hemoglobin concentration (Fhb) and the opportunity to detect a colorectal cancer in subsequent campaign has been shown.

Aim: To predict the severity of colorectal lesions based on Fhb measured during previous colorectal cancer screening campaign.

Methods: This etiological study included 293750 patients aged 50-74, living in Auvergne-Rhône-Alpes (France). These patients completed at least two FIT [test and test] between June 2015 and December 2019. Delay between test and test was > 1 year and test result was negative (< 150 ngHb/mL). The severity of colorectal lesions diagnosed at test was described according to Fhb measured at test [Fhb]. The relationship between the severity classified in seven ordinal categories and the predictive factors was analyzed in an ordered multivariate polytomous regression model.

Results: The test positive rate was 4.0%, and the colonoscopy completion rate was 97.1% in 11594 patients who showed a positive test. The colonoscopy detection rate was 77.7% in those 11254 patients who underwent a colonoscopy. A total of 8748 colorectal lesions were detected (including 2182 low-risk-polyps, 2400 high-risk-polyp, and 502 colorectal cancer). The colonoscopy detection rate varied significantly with Fhb [0 ngHb/mL: 75.6%, (0-50 ngHb/mL): 77.3%, (50-100 ngHb/mL): 88.7%, (100-150 ngHb/mL): 90.3%; = 0.001]. People with a Fhb within (100-150 ngHb/mL) ( = 0.001) were 2.6 (2.2; 3.0) times more likely to have a high severity level compared to those having a Fhb value of zero. This risk was reduced by 20% in patients aged 55-59 compared to those aged < 55 [adjusted odds ratio: 0.8 (0.6; 1.0)].

Conclusion: The study showed that higher Fhb is correlated to an increased risk of severity of colorectal lesions. This risk of severity increased among first-time participants (age < 55) and the elderly (≥ 70). To avoid the loss of chance in these age groups, the FIT positivity threshold should be reduced to 100 ngHb/mL. The other alternative would be to reduce the time between the two tests in these age groups from the current 2 years to 1 year.

Citing Articles

Changes in faecal haemoglobin values over sequential rounds of faecal immunochemical tests (FIT) in a surveillance population.

Mortell G, Wooldrage K, Murphy G, Cross A BMJ Open Gastroenterol. 2025; 12(1).

PMID: 39933781 PMC: 11843008. DOI: 10.1136/bmjgast-2024-001651.

References
1.
Ribbing Wilen H, Blom J, Hoijer J, Hultcrantz R . Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels. J Gastroenterol Hepatol. 2018; 34(1):103-112. DOI: 10.1111/jgh.14373. View

2.
Koivogui A, Mab G, Benamouzig R . Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program. Am J Gastroenterol. 2018; 113(12):1891-1899. PMC: 6768603. DOI: 10.1038/s41395-018-0367-2. View

3.
Denters M, Deutekom M, Bossuyt P, Stroobants A, Fockens P, Dekker E . Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology. 2011; 142(3):497-504. DOI: 10.1053/j.gastro.2011.11.024. View

4.
Pickhardt P, Pooler B, Kim D, Hassan C, Matkowskyj K, Halberg R . The Natural History of Colorectal Polyps: Overview of Predictive Static and Dynamic Features. Gastroenterol Clin North Am. 2018; 47(3):515-536. PMC: 6100796. DOI: 10.1016/j.gtc.2018.04.004. View

5.
Pin Vieito N, Zarraquinos S, Cubiella J . High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. World J Gastroenterol. 2019; 25(19):2383-2401. PMC: 6529892. DOI: 10.3748/wjg.v25.i19.2383. View